Top Artificial Intelligence Stocks To Keep An Eye On – December 6th

BigBear.ai, SentinelOne, and Tempus AI are the three Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. Artificial intelligence stocks are shares of companies whose core business is developing, selling, or deploying AI technologies (machine learning, deep learning, NLP, computer vision) or of firms that stand to gain materially from AI-driven products and services. Investors view them as a way to gain growth exposure to AI-driven revenue and productivity gains, but should weigh higher valuations, rapid technological change, competitive risk, and regulatory or ethical uncertainties that can increase volatility. These companies had the highest dollar trading volume of any Artificial Intelligence stocks within the last several days.

BigBear.ai (BBAI)

BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.

SentinelOne (S)

SentinelOne, Inc. operates as a cybersecurity provider in the United States and internationally. Its Singularity Platform delivers an artificial intelligence-powered autonomous threat prevention, detection, and response capabilities across an organization's endpoints, cloud workloads, and identify credentials, which enables seamless and autonomous protection against a spectrum of cyber threats.

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.